Innovating Tumor Homing, Scalable Allogeneic Therapy Design to Unlock Cost Effective Cell Therapy Access

• Advancing tumor homing technology to improve targeting precision
• Highlighting game-changing manufacturing COGs
• Allogeneic out of the box

Speakers:

Tim Gallagher

Chief Business Officer & Chief Operating Officer

PhosphoGam